Stocks / Pharmaceuticals

INSMPharmaceuticals

Insmed, Inc.
$125.601d -2.2%5d -1.0%settled close · 2026-09-10
Mkt cap $30B (9/8)β 0.4852w $92–152Shares 215.6MInd. Pharmaceutical PreparationsNasdaq since 2000Emp. 1,664HQ Bridgewater, NJinsmed.com
Who’s talkingIdea Scout · free

Who’s talking about INSM

No tracked investor commentary on INSM yet — the corpus grows weekly.
Idea Scout tracks who’s talking across television, podcasts, and interviews — every stance dated to the appearance it came from. Sign up free →
Earnings

Next report: 28 Oct 2026

Confirmed date · consensus EPS -0.48. Reactions below are the next settled session over the prior close.
The options tape

Notable options days

Sessions in the last 120 where INSM’s settled options volume ran ≥ 2× its trailing 20-session baseline, or delta-dollar flow ran ≥ 2.5× — 11 of 120 sessions qualified.

The qualifying dates are the free record. Close, flow, call/LEAPS mix and the 20-session outcome — for every session below — are Brief subscriber content.
DateCloseRVOL Δ$ flow ($M)Call % LEAPS %+20 sess.
2026-09-10
2026-08-07
2026-08-06
2026-08-05
2026-08-04
2026-07-30
2026-07-22
2026-07-21
2026-06-30
2026-06-10
2026-06-01
+20 sess. = raw price change over the following 20 sessions — not market-adjusted; the tape tells you where to look, not what happens next.
Today’s tape on INSM is in this morning’s Brief. Get The Brief — $20/mo →